US multinationals grapple with soaring dollar

The rapid rise of the U.S. dollar since the start of the year is a double-edged sword for American multinational companies, pushing some of them to decide whether to hedge or reposition their activities abroad to avoid fallout.    

For an importer, the surge in the greenback against the euro, yen or British pound is a plus, because it makes the products they buy cheaper.  

But for a U.S. export company, products sold in dollars have become more expensive, which increases the risk of losing clients and seeing sales decline.  And they also lose money when converting foreign revenue back into to dollars.    

Many firms already revised their earnings forecasts for the year to account for the changing exchange rate, including computing giant Microsoft, which warned its quarterly sales will fall by $460 million and its net profit by $250 million due to the currency hit.    

Adobe, Salesforce, Biogen and Pfizer have all warned that the dollar's rapid rise will have a greater impact on their accounts than expected.            

Companies that generate most of their revenue outside of the U.S. are the most exposed, starting with tech giants, medical equipment makers and service companies, according to Kyriba, a corporate cash management platform.    

Kyriba estimates the currency effects could mean a $40 billion hit to earnings of S&P 500 firms in the first half of the year.    

The Federal Reserve's decision to aggressively hike interest rates to combat rampant inflation, combined with an influx of funds into the country from investors looking for a safe haven in uncertain times, have combined to boost the U.S. dollar.    

The greenback has risen 13 percent compared to the euro over the last 12 months, approaching...